Chimeric Antigen Receptor T-cell Immunotherapy

This study commissioned by the European Patent Office demonstrates the application of patent information to gain insights into specific technological fields, in this case Chimeric Antigen Receptor T-cell Immunotherapy (CAR T-cell Immunotherapy). A peer-reviewed paper was published in Nature Biotechnology and featured in a recent online seminar.